Analyst Expectations for Intercept Pharma's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Intercept Pharma (NASDAQ:ICPT) stock. The average price target is $19.2, implying an upside from the current price of $18.71. The average price target has increased by 22.53% over the past month.
September 27, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have given an average price target of $19.2 for Intercept Pharma, implying an upside from the current price. The target has increased by 22.53% over the past month.
The average price target given by analysts suggests a potential upside for Intercept Pharma's stock. This, coupled with the fact that the target has increased by 22.53% over the past month, indicates a positive sentiment towards the stock. Therefore, it's likely that the stock price may increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100